Octave Specialty Group, Inc.
5.01USD
+0.0600 (+1.21%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $-0.05▼ | $0.05 | 0 | 2 |
| Next quarter | $-0.11▼ | $0.04 | 0 | 2 |
| Current year | $0.17▼ | $0.45 | 0 | 2 |
| Next year | $0.56▼ | $0.87 | 0 | 2 |
Beat in 3 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $-0.01 | $-0.04 | -0.04 (-700.0%) |
| 2026-03-31 | $0.02 | $0.37 | +0.35 (+2366.7%) |
| 2025-12-31 | $-0.21 | $-0.02 | +0.18 (+90.2%) |
| 2025-09-30 | $-0.23 | $-0.21 | +0.02 (+8.7%) |
16 ratings from 9 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Truist Securities | Maintained | Buy | $10 $15 | Nov 12, 2025 |
| Truist Securities | Initiated | Buy | $10 | Jul 15, 2025 |
| Imperial Capital | Downgraded from Outperform | In-Line | — | May 6, 2014 |
| Imperial Capital | Upgraded from Underperform | Outperform | $7 | Apr 1, 2014 |
| Barclays | Maintained | Underweight | $6 $2 | Nov 7, 2012 |
| Credit Suisse | Downgraded from Outperform | Neutral | $8 $1 | Oct 23, 2012 |
| Jefferies | Maintained | Hold | $3 $1 | Oct 23, 2012 |
| Jefferies | Maintained | Hold | $3 $1 | Oct 22, 2012 |
| Dahlman Rose | Downgraded from Hold | Sell | $0.5 | Oct 22, 2012 |
| Clarkson Capital Markets | Downgraded from Outperform | Market Perform | — | Oct 22, 2012 |
| Deutsche Bank | Maintained | Hold | — | Oct 22, 2012 |
| Jefferies | Maintained | Hold | $6 $3 | Oct 22, 2012 |
| Global Hunter Securities | Initiated | Neutral | — | Sep 13, 2012 |
| Deutsche Bank | Maintained | Hold | $7 $6 | Aug 2, 2012 |
| Jefferies | Maintained | Hold | $7 $6 | Aug 2, 2012 |
| Jefferies | Maintained | Hold | $10 $7 | Jul 24, 2012 |
48 filings from 14 insiders · 0 buy / 0 sell over 6m
Officers and directors of OSG, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| SMITH R. SHARONChief Operating Officer | Other | 11.8k | — | — | Jul 9, 2026 |
| TRICK DAVIDChief Financial Officer | Other | 13.2k | — | — | Jul 9, 2026 |
| LEBLANC CLAUDE L.Chief Executive Officer | Other | 39.4k | — | — | Jul 9, 2026 |
| AHN CRISTINA E.Officer | Other | 835 | — | — | Mar 10, 2026 |
| SMITH R. SHARONChief Operating Officer | Other | 1.5k | — | — | Mar 3, 2026 |
| TRICK DAVIDChief Financial Officer | Other | 1.7k | — | — | Mar 3, 2026 |
| LEBLANC CLAUDE L.Chief Executive Officer | Other | 24.5k | — | — | Mar 3, 2026 |
| LEBLANC CLAUDE L.Chief Executive Officer | Buy | 12.0k | $7.59 | $91k | Jan 2, 2026 |
| SMITH R. SHARONOfficer | Buy | 20 | $10.25 | $205 | Nov 12, 2025 |
| LEBLANC CLAUDE L.Chief Executive Officer | Buy | 25.0k | $8.54 | $214k | Oct 1, 2025 |
| SMITH R. SHARONOfficer | Other | 147.9k | — | — | Sep 30, 2025 |
| SMITH R. SHARONOfficer | Other | 148.4k | — | — | Sep 30, 2025 |
| TRICK DAVIDChief Financial Officer | Other | 207.9k | — | — | Sep 30, 2025 |
| LEBLANC CLAUDE L.Chief Executive Officer | Other | 854.7k | — | — | Sep 30, 2025 |
| IGLESIAS LISA GDirector | Other | 67.8k | — | — | Sep 29, 2025 |
| MATUS KRISTI ANNDirector | Other | 39.2k | — | — | Sep 29, 2025 |
| PRICE MICHAEL DDirector | Other | 39.2k | — | — | Sep 29, 2025 |
| KSENAK STEPHEN MICHAELGeneral Counsel | Other | 129.1k | — | — | Sep 29, 2025 |
| STEIN JEFFREY SCOTTDirector | Other | 167.8k | — | — | Sep 29, 2025 |
| HAFT IAN DAVIDDirector | Other | 131.9k | — | — | Sep 29, 2025 |
Analyst Ratings
3 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 1 | 2 | 0 | 0 | 0 | Buy1.67 |
| 1 mo ago | 0 | 2 | 0 | 0 | 0 | Buy2.00 |